InvestorsHub Logo
Followers 16
Posts 1062
Boards Moderated 0
Alias Born 09/01/2019

Re: McMagyar post# 16257

Tuesday, 10/25/2022 11:26:54 AM

Tuesday, October 25, 2022 11:26:54 AM

Post# of 16699
AGN is targeting Stroke treatment with a sub hallucinogenic dose as seen at the CRL pre clinical work, IMO...GLTA...

https://www.globenewswire.com/en/news-release/2021/11/01/2324220/0/en/Algernon-Pharmaceuticals-Establishes-6-hours-as-Optimum-Treatment-Period-for-DMT-in-Neuron-Study.html